About Us

arrow-icon
Back to About Us
member-photo-1

Ingrid Skop, M.D., F.A.C.O.G.

Senior Fellow and Director of Medical Affairs

Ingrid Skop, M.D., F.A.C.O.G., is Senior Fellow and Director of Medical Affairs for Charlotte Lozier Institute, leveraging more than 25 years’ experience as a practicing obstetrician-gynecologist to support research and policies that respect the dignity of every human life.

Dr. Skop received her Bachelor of Science in physiology from Oklahoma State University and her medical doctorate from Washington University School of Medicine. She completed her residency in obstetrics and gynecology at the University of Texas Health Science Center at San Antonio. Dr. Skop is a Fellow of the American College of Obstetricians and Gynecologists, where she uses science and statistics to counter pro-abortion agendas, and is a lifetime member of the American Association of Pro-Life Obstetricians and Gynecologists.

Prior to joining Charlotte Lozier Institute, Dr. Skop served for over 25 years in private practice in San Antonio, where she delivered more than 5,000 babies and personally cared for many women who had been harmed, physically and emotionally, from complications due to abortion. She continues to serve as Medical Director of Any Woman Can, a pregnancy resource center that provides support and free counseling to women in crisis. She also serves as medical director and board member of The Source in Austin and Houston, a consortium of full-service women’s centers with a Christian worldview.

Dr. Skop’s research on maternal mortality, abortion, and women’s health has been published in multiple peer-reviewed journals. Additionally, she has provided expert testimony at both the state and federal levels on legislation related to abortion, including standing firm against prominent pro-abortion politicians who choose not to follow the science regarding fetal heartbeat and development.

Dr. Skop is married to a physician and is the proud mother of two sons and a daughter.

 

 

 

Latest Research & News

  • Questions and Answers on Late-Term Abortion | May 16, 2022

    First published: February 2019 Last updated: May 16, 2022   To view this fact sheet as a PDF, see: Fact Sheet: Questions and Answers on Late-Term Abortion   What is a Late-Term Abortion?   “Late-term” abortion is an imprecise term, but under any “formal” definition offered or as accepted by the public at large late-term […]

  • Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child | May 17, 2022

    To view this fact sheet as a PDF, see:  Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child   Recent Statements   Many media sources have recently lamented the possibility that women may die or suffer severe harm if they are denied “medically indicated” abortions in states that have implemented elective abortion […]

  • No-Test Chemical Abortion Provision: Can it be Justified? | April 28, 2022

    This is issue 81 in CLI’s On Point Series. To view this report as a PDF, see: No-Test Chemical Abortion Provision: Can it be Justified?   Despite their verbal commitment to safe abortion provision, abortion advocates are advancing a dangerous strategy. The U.S. Food and Drug Administration (FDA) requirements for in-person medical evaluation prior to […]

  • The Evolution of “Self-Managed” Abortion: Does the Safety of Women Seeking Abortion Even Matter Anymore? | March 1, 2022

    This is Issue 77 in CLI’s On Point Series. To view this report as a PDF, see: The Evolution of “Self-Managed” Abortion: Does the Safety of Women Seeking Abortion Even Matter Anymore?   A particularly malignant form of “misinformation” is being spread to women today.  Flawed information regarding “self-managed” abortion has the potential to seriously […]

  • Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions | December 16, 2021

    By: David C. Reardon, Ph.D., Donna J. Harrison M.D., Ingrid Skop M.D. Maka Tsulukidze, M.D., Ph.D, M.P.H.,Christina A. Cirucci, M.D., James Studnicki, Sc.D., M.P.H. M.B.A   This is issue 20 of CLI’s American Report Series. To View this Report as a PDF, see: Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: […]

  • The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health | July 30, 2020

    This is Issue 49 in CLI’s On Point Series. To view this report as a PDF, see: On Point 49: The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health   A trend of mounting concern is occurring in abortion provision.  When elective induced abortion was legalized in the United States in 1973, one oft-cited motivation […]